Clinical Trial Update: Observational Prospective Study on Patients Treated With Norditropin®

View source ↗

Summary

An observational prospective study assesses outcomes in patients treated with Norditropin (somatropin) for growth hormone-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Growth Hormone Deficiency
• Intrauterine Growth Restriction
• Noonan Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Status: COMPLETED